Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 7 de 7
Filter
Add more filters










Database
Language
Publication year range
1.
Bone Marrow Transplant ; 33(9): 955-62, 2004 May.
Article in English | MEDLINE | ID: mdl-15034542

ABSTRACT

Stem cell transplantation has assumed a prominent place in the treatment of multiple myeloma, but relative to patients with other malignancies there is surprisingly little information about the adjustment difficulties and quality-of-life changes that these patients experience. This study examined psychosocial and functional deficits among myeloma patients assessed at a uniform period during their initial diagnostic evaluation, prior to beginning protocols at a transplant center. Validated self-report measures and clinician rating scales were used to assess 213 patients. Outcomes evaluated included emotional distress (Hospital Anxiety and Depression Scale, Brief Symptom Inventory), depression (Hamilton Depression Rating Scale), physical functioning, pain, and energy (SF-12). A significant proportion of patients experienced compromised psychosocial and physical functioning. Roughly one-third reported clinically elevated levels of distress, anxiety, and depression. In all, 59% scored below age-adjusted norms for daily physical functioning, 58% reported at least moderate levels of pain, and over 80% noted at least moderate fatigue. Clinical and demographic correlates of these outcomes were examined. These findings are among the first to characterize quality-of-life outcomes among myeloma patients in the transplant setting, and indicate that many patients experience considerable supportive care needs even prior to beginning aggressive regimens. Results highlight the importance of early screening.


Subject(s)
Multiple Myeloma/psychology , Multiple Myeloma/therapy , Stem Cell Transplantation/methods , Transplantation, Autologous/methods , Adaptation, Psychological , Adult , Aged , Aged, 80 and over , Depression , Female , Humans , Male , Middle Aged , Quality of Life , Stem Cell Transplantation/psychology , Stress, Psychological , Transplantation, Autologous/psychology , Treatment Outcome
2.
J Immunol ; 154(8): 4174-86, 1995 Apr 15.
Article in English | MEDLINE | ID: mdl-7535824

ABSTRACT

In a previous analysis of HIV-1-specific CTLs in lymphoid organs from HIV-seropositive patients, we reported high frequencies of in vivo differentiated CTLs directed against two immunodominant regions in the central and in the C-terminal part of the HIV-1 Nef protein. The present study analyzes the epitopes recognized by CTLs in the carboxyl terminus of Nef (amino acids 182-205). In addition to several epitopes that are recognized in association with different HLA molecules (A1, A2, A25(10), B35, B52), we defined an optimal nonapeptide (190-198). This nonapeptide was recognized by CTLs down to nanomolar concentrations in the context of at least two HLA molecules, HLA-B52 and HLA-A2, including three HLA-A2 subtypes: HLA-A2.1, -A2.2, and -A2.4. We also determined the relative frequencies of effector CTLs directed against peptide 190-198 to be as high as 10(-4), as opposed to lower frequencies ranging between 5 x 10(-5) and 5 x 10(-6) observed for the other peptides recognized in the same region, thus confirming the optimal presentation of this nonapeptide in vivo. Molecular modeling of the interactions between HLA-A2.1 and Nef peptide 190-198 suggests the formation of a stable complex and allowed us to study sequence motifs that are important for the binding of the HIV-1 peptide in the pockets of the HLA-A2.1 molecule.


Subject(s)
Gene Products, nef/immunology , HIV Antigens/immunology , HIV Seropositivity/immunology , HIV-1/immunology , HLA-A2 Antigen/immunology , HLA-B Antigens/immunology , T-Lymphocytes, Cytotoxic/immunology , Base Sequence , Computer Simulation , Cytotoxicity, Immunologic , Epitope Mapping , Epitopes/chemistry , HLA-B52 Antigen , Humans , Immunity, Cellular , In Vitro Techniques , Lymph Nodes/immunology , Models, Molecular , Molecular Sequence Data , Protein Binding , Spleen/immunology , nef Gene Products, Human Immunodeficiency Virus
3.
Psychol Rep ; 73(3 Pt 2): 1218, 1993 Dec.
Article in English | MEDLINE | ID: mdl-8115572

ABSTRACT

To examine the social desirability correlates for acceptance of rape myths, university students, 134 women and 56 men, completed the Rape Myth Acceptance Scale and the Marlowe-Crowne Social Desirability Scale. The mean score on the former was 98.8 and for the latter 14.3. Over-all, scores on the Marlowe-Crowne Social Desirability Scale were not significantly correlated with scores on the Rape Myth Acceptance Scale (r = .10). Values were .03 for women and .16 for men.


Subject(s)
Gender Identity , Rape/psychology , Social Desirability , Adult , Bias , Female , Humans , Male , Personality Inventory/statistics & numerical data , Prejudice , Psychometrics , Stereotyping
4.
Arch Virol ; 128(1-2): 81-95, 1993.
Article in English | MEDLINE | ID: mdl-7678193

ABSTRACT

A panel of newly isolated murine monoclonal antibodies is described which are specific for the Nef protein of the human immunodeficiency virus type 1 (HIV-1). Epitope mapping using recombinant Nef-related proteins, synthetic peptides and lipopeptides showed 3 independent antigenic determinants located within the regions of amino acids 83-93, 175-190 and 86-166 of the Nef protein. None of the monoclonal antibodies reacted with recombinant Nef proteins of HIV-2.


Subject(s)
Antibodies, Monoclonal/immunology , Epitopes/immunology , Gene Products, nef/immunology , HIV-1/immunology , Amino Acid Sequence , Animals , Antibodies, Viral/immunology , Antibody Specificity , Female , Mice , Mice, Inbred BALB C , Molecular Sequence Data , Peptide Fragments/chemical synthesis , Peptide Fragments/immunology , Recombinant Fusion Proteins/immunology , nef Gene Products, Human Immunodeficiency Virus
6.
AIDS ; 6(1): 25-34, 1992 Jan.
Article in English | MEDLINE | ID: mdl-1371924

ABSTRACT

OBJECTIVE: To study the immunological and immunohistochemical nature of HIV-1 Nef. DESIGN: Monoclonal anti-Nef antibodies were generated and used to identify antigenic epitopes in Nef, to study immunological cross-reactivity between Nef from different isolates and to reveal the subcellular localization of Nef. METHODS: Monoclonal antibodies against recombinant HIV-1 Nef protein (BRU isolate) were generated in BALB/c mice. The epitope mapping was carried out with the use of overlapping 15-20mer lipopeptides linked to a lipid group at the amino-terminus. Immunoperoxidase method was used for histochemical studies. RESULTS: Ten stable antibody-producing clones, mainly of the immunoglobulin (Ig) G1 subtype, with strong Western blot and enzyme-linked immunosorbent assay reactivity toward the recombinant Nef protein, were obtained. The epitopes recognized were located on amino-acid sequences 21-41, 31-50, 51-71, 61-80, 151-170, 161-180, and 171-190. All 10 monoclonal antibodies also reacted with the native Nef of HIV-1BRU, and eight reacted with native HIV-1IIIB. Most antibodies also reacted with Nef from more divergent HIV-1 strains. In Western blotting, two forms of Nef (24 and 27 kDa) were observed with most isolates studied. Immunohistochemical staining of HIV-1-infected H9 or MT-4 lymphoid cells demonstrated that Nef was expressed mainly in the Golgi complex and at the nuclear membrane, but occasionally also in the nucleus. The nuclear localization of Nef was especially frequent in the HIV-1-infected MT-4 cells. CONCLUSIONS: Our findings suggest that Nef is expressed in two isomorphic forms, and that it may also act as a nuclear protein and thus have a direct regulatory function at the RNA/DNA level.


Subject(s)
Antibodies, Monoclonal/immunology , Antigenic Variation , Gene Products, nef/immunology , Animals , Blotting, Western , Cell Line , Enzyme-Linked Immunosorbent Assay , Epitopes , HIV Antibodies/immunology , HIV Antigens/immunology , Humans , Immune Sera , Immunohistochemistry , Mice , Mice, Inbred BALB C , Recombinant Proteins/immunology
SELECTION OF CITATIONS
SEARCH DETAIL
...